← Company intelligence

Robot maker · registered

Wearable Robotics

Corporate marketwearablesmedicalCurated record

Bilateral upper-limb rehabilitation exoskeleton (ALEx RS) delivers personalized neuromotor retraining via closed-loop impedance control across 4 actuated + 2 passive DOF; adapts assistance levels in real time to patient effort; integrates VR/AR feedback for cognitive-motor training; derived from 25 years of PERCRO laboratory research at Scuola Superiore Sant'Anna; CE Class IIa medical device; ISO 13485 quality system; ALEx RS 2.0 in development adds modular hand module.

HeadquartersGhezzano, IT
Founded2014
Corporate funding$6M
Team11-50
Deployments1
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersLucia Lencioni (CEO), Fabio Salsedo (CTO)
Regions servedEurope, North America
Countries deployedIT, CH
Service footprintExoskeleton systems in 50+ clinical hospitals and rehabilitation centres across 20+ countries; HQ in Pisa, Italy; industrial ergonomics division under Nexum Robotics brand; targeting North America expansion.
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinewearables

ALEx RS

  • 92% of natural arm workspace coverage

    vendor-stated percentage of healthy human arm workspace accessible by the bilateral exoskeleton

    Claim source
  • 6 degrees of freedom (4 actuated, 2 sensorized-passive)

    vendor-stated joint count: shoulder abduction-adduction, rotation and flexion-extension, elbow flexion-extension (actuated); forearm pronation-supination and wrist flexion-extension (passive sensorized)

    Claim source
  • 5.6 kg exoskeleton moving parts; 160 kg total device weight

    vendor-stated weight of wearable arm structure vs. full system including workstation frame

    Claim source
  • CE Class IIa medical device certification

    vendor-stated European regulatory classification for active therapeutic medical device

    Claim source
Machinewearables

ALEx RS 2.0

  • Modular hand module for full shoulder + elbow + hand rehabilitation; reduced device dimensions for multi-unit clinical settings

    vendor-stated planned enhancements over ALEx RS 1.0; in development, co-funded by EU NextGenerationEU

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-04-0150+ clinical centers (unnamed) across 20 countriesrehabilitation_clinicIT50Announcement
CA

Funding history

Publicly announced rounds

Investors on recordCDP Venture Capital (Accelerators Fund)MITO TechnologyLIFTTSIMESTRoboITToscana Next
TL

Company timeline

Milestones and announcements

2026-04-03Closed €5 million Series A led by CDP Venture Capital (Accelerators Fund) to scale North America expansion and develop ALEx RS 2.0The Next Web
2022-01-01Completed final acquisition of patent portfolio from Scuola Superiore Sant'AnnaWearable Robotics
2019-01-01ISO 13485 certification and CE Class IIa medical device compliance achieved for ALEx RSWearable Robotics
2016-01-01First multicenter clinical trial for ALEx RS initiated with EPFL, University Hospital of Geneva, and University Hospital of Pisa; ISO 9001 certification achievedWearable Robotics
2014-01-01Founded as spin-off of Scuola Superiore Sant'Anna; acquired 6 exclusive patents from PERCRO laboratoryWearable Robotics
2013-01-01Founding research group wins Marzotto Prize for best technology-driven business ideaWearable Robotics
SC

Source ledger

7 unique public sources